Clinical response to sunitinib as a multitargeted tyrosine-kinase inhi | OTT
Selected clinical trials of sunitinib. GIST, gastrointestinal stromal... | Download Table
CANCER CLINICAL TRIALS - Argos Therapeutics
Sunitinib shows efficacy in pheochromocytoma and paraganglioma
Sunitinib maleate | Nature Reviews Drug Discovery
Clinical trials of Sunitinib in patients with thyroid cancer. | Download Table
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial - European Urology
Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma - ScienceDirect
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma | NEJM
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma | NEJM
Sunitinib: the antiangiogenic effects and beyond | OTT
ASCO GU 2018: Phase III Trial of Adjuvant Sunitinib in Patients with High-risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials - European Journal of Cancer
Currently active clinical trials on the use of sunitinib for renal cell... | Download Scientific Diagram
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial - ESMO Open
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial - European Journal of Cancer
Sunitinib ongoing clinical trials. | Download Scientific Diagram
Selected clinical trials investigating sunitinib in pancreatic... | Download Scientific Diagram
Clinical trials with presurgical sunitinib. | Download Scientific Diagram
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features | Journal of Clinical Oncology
Selected clinical trials investigating sunitinib in pancreatic... | Download Scientific Diagram
Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence | Semantic Scholar
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial - The Lancet Oncology
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet
